Quotient Therapeutics

Our Co-Founder and CEO, Jacob Rubens recently joined Theral Timpson for an episode on the Mendelspod podcast. Tune in as he highlights how our #SomaticGenomics platform is revolutionizing the #DrugDiscovery and development process. Listen to the full podcast here: https://bit.ly/4fXDsdy

We’re honored to be named a 2024 BioTech Breakthrough Awards winner for Biotech Startup of the Year! This recognition highlights our commitment to innovation as we use our #SomaticGenomics platform to pioneer novel therapies. Learn more about the other 2024 winners here: https://bit.ly/4fq1IFr

#SomaticGenomics has near limitless possibilities in driving transformative treatments across a multitude of therapeutic areas. Learn more about how we are using our platform to advance target identification and #DrugDevelopment: https://bit.ly/3UzKYTP

Join us in welcoming Prof Sir Mene Pangalos, PhD, to our Board of Directors! His extensive experience in R&D will be deeply valuable as we advance our #SomaticGenomics platform to develop first-in-class medicines for a wide range of diseases. Read more in our press release: https://bit.ly/3UGllkq

Somatic mutations are changes to #DNA that accumulate in cells over our lifetime. At Quotient, we're using our platform to explore this vast genetic diversity inside us to identify new therapeutic opportunities. Learn more: https://bit.ly/3XVmLYX

Quotient's #SomaticGenomics platform is the result of a groundbreaking collaboration with world-leading experts in the field. Our academic co-founders have made invaluable contributions, pushing the boundaries of what was thought possible in science. Discover more about their pioneering work here: https://bit.ly/4eXbluJ

While we're focused on progressing #SomaticGenomics, it's also important for us to connect as a team. We all came together last month for an offsite event that highlighted what matters most: community and collaboration.

We’re excited to be on Labiotech.eu's list of top 10 European #biotech startups to watch in 2024! Since our launch last November, we've expanded our team, formed a collaboration with Pfizer, and continued to advance our #SomaticGenomics platform. Here's to more progress in the year ahead! View the full list here: https://bit.ly/3XW02x3

On September 20, members of our team are attending #eSCAMPS2024, a one-day conference exploring the success stories of leading scientists & students. Visit us at our booth to learn about our work in #SomaticGenomics. We hope to see you there! Learn more about us here: https://bit.ly/3MKoBGX eSCAMPS symposium

What if the idea that each of us has one genome is off by over a trillion-fold? Genetic changes make each cell's genome slightly different. At Quotient, we’re using the first ever #SomaticGenomics platform to explore this universe of somatic genome variation and reveal novel drug targets. Learn more: https://bit.ly/47pFujv